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We have previously reported that stress analgesia sensitive to and insensitive to opiate antagonists can be differentially produced in 
rats by varying the severity or temporal pattern of inescapable footshock. In these studies, we give further evidence for the opioid and 
non-opioid bases of these paradigms of stress analgesia. We find that naloxone-sensitive analgesia demonstrates tolerance with re- 
peated stress and cross-tolerance with morphine, whereas naloxone-insensitive analgesia demonstrates neither of these characteris- 
tics. Moreover, different forms of opioid, but not non-opioid, stress analgesia manifest cross-tolerance with each other. These data are 
discussed in terms of the similarities and differences between two forms of opioid stress analgesia. 
INTRODUCTION 
Multiple pain- inhibi tory systems appear  to exist in 
the rat that  function via descending influences from 
the brain to the spinal cord 36.39. It has been proposed  
that activation of such systems underl ies  the analge- 
sic effects of such exper imenta l  and clinical proce-  
dures as electrical brain stimulation26,29,40, acupunc- 
ture 25, placebo tS, and the adminis t ra t ion of opiate  
drugs 26. The finding that  various stressors (including 
thermal challenge3.6,14, restraint  2, hypoglycemia  4,27, 
conspecific defeat  28 and electric shock 1,5,9) markedly  
reduce pain responsiveness suggested that stress is a 
natural  trigger for act ivation of these endogenous  
pain-inhibi tory substrates.  Stress-induced analgesia,  
however,  has p r o v e n  to be a complex phenomenon.  
For  example ,  some of the original studies found that 
stress analgesia from footshock was blocked by the 
opiate  antagonist ,  naloxone 1,5 and demons t ra ted  
cross-tolerance with morphine  5. Such findings indi- 
cated that endogenous  opioid  pept ides  media te  stress 
analgesia. By appl icat ion of these same criteria,  how- 
ever, o ther  early studies using footshock found stress 
analgesia to be independen t  of opioids 9. 
In our initial work,  using inescapable footshock,  
we repor ted  that opioid  and non-opioid  mechanisms 
of stress analgesia could be differential ly act ivated by 
varying the tempora l  pa ramete r s  of the stressor L6. 
More specifically, whereas 20-30 min of 2 .5 -3 .0  mA 
intermit tent  footshock (1 s on every 5 s) elicited anal- 
gesia sensitive to low doses of opiate  antagonists  and 
manifesting tolerance with repea ted  stress exposure 
and cross-tolerance with morphine ,  3 rain of continu- 
ous footshock at these same intensities yielded an 
equipotent  analgesia showing none of these charac- 
teristics 16,18,19. Other  investigators have also report-  
ed differential  product ion of opioid and non-opioid 
forms of stress analgesia using these same criteria for 
opioid mediat ion s,37,39. Fur ther  emphasizing the sep- 
arateness of the substrates underlying opioid and 
non-opioid forms of stress analgesia,  we found no 
cross-tolerance between them 32. That  is, repea ted  
exposure to one stress paradigm did not reduce the 
analgesic effect of initial exposure to the other.  
We have recently repor ted  that a second form of 
stress analgesia sensitive to low doses of opiate  an- 
tagonists can be produced  by continuous footshock of 
briefer  durat ion or lower intensity than that produc-  
ing non-opioid analgesia 33,36. The purpose  of the 
present  exper iment  was to de termine  whether  this 
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second naloxone-sensitive form of stress analgesia 
met other criteria of opioid mediation. We began by 
testing for cross-tolerance between morphine and 
several paradigms of naloxone-sensitive and nalox- 




Thirty male Sprague-Dawley  rats (400-450 g) 
were purchased from Simonsen Laboratories and 
randomly divided into two groups. One group was 
given daily injections of morphine (10 mg/kg, s.c.) 
for the duration of the experiment. The other group 
received daily injections of  isotonic saline for the 
same time period. After  7 days of injections, all rats 
were exposed to 1 rain of continuous footshock, 4 min 
of continuous footshock, and 20 min of intermittent 
(1 s on every 5 s) footshock on successive days in 
counterbalanced order. Footshock consisted of 2.5 
mA 60 Hz sine waves administered through the grid 
floor of a 20 x 23 x 20 cm Plexiglas chamber.  These 3 
stress paradigms, differing in their temporal  parame- 
ters, have previously been shown to yield 'opioid '  (1 
and 20 rain) and 'non-opioid '  (4 min) stress analgesia 
as defined by sensitivity to opiate antagonists 36. 
In a separate experiment, 20 additional rats were 
divided into two equal groups and injected with 
either morphine (10 mg/kg, s.c.) or saline daily for 
the duration of  the experiment. On days 8 and 9, all 
animals were exposed to 3 min of  footshock at 2.0 
mA and 3.5 m A  in counterbalanced order. We have 
previously shown that these two footshock para- 
digms, differing in shock intensity, yield analgesia 
that is sensitive (2.0 mA)  and insensitive (3.5 mA)  to 
opiate antagonists 36. 
Pain responsiveness was assessed by the tail-flick 
test 7. We 19,36 and others have used a variety of anal- 
gesiometric methods in studies of stress analgesia as- 
suring that the basic phenomenon has generality 
across tests. Prestress baselines were defined as the 
mean of  the last 3 of  5 tail-flick trials. Ten poststress 
tail-flick latencies were taken at 1 rain intervals be- 
ginning 1 min after footshock cessation. Exposure to 
the radiant heat source for any one tail-flick trial was 
limited to 7 s to minimize tissue damage. 
Data were analyzed using separate 2-way (group 
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Fig. 1. Diagrammatic representation of how analgesia scores 
were calculated for each animal. Tail-flick latencies were 
plotted for each of the 10 poststress trials. Analgesia score was 
defined as the area under the resultant curve, using the ani- 
mal's baseline latency as the ordinate's zero point (hatched 
area). 
x trials) analyses of  variance for each stress analge- 
sia paradigm. For  illustrative purposes only, results 
were converted to 'analgesia scores' calculated for 
each animal as follows: tail-flick latencies were 
plotted for each of the 10 poststress trials. The anal- 
gesia score was defined as the area under the resul- 
tant curve, using that animal's baseline latency as the 
ordinate's zero point (Fig. 1). 
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Fig. 2. Stress analgesia elicited in morphine-tolerant and sa- 
line-treated controls by several footshoek paradigms. A: mor- 
phine-tolerant animals demonstrate significantly less analgesia 
than controls (cross-tolerance) when shocked with 1 rain of 
continuous or 20 min of intermittent 2.5 mA footshock but not 
4 rain of continuous footshock at this same intensity. B: mor- 
phine-tolerant animals also demonstrate significant cross-toler- 
ance when shocked with 2.0 mA, but not 3.5 mA, footshock for 
3 rain. 
Results 
Morphine tolerant animals showed significantly 
less stress analgesia than saline controls after both 
1 min of continuous and 20 min of intermittent foot- 
shock at 2.5 mA (Fig. 2A). In contrast, morphine tol- 
erant animals did not differ from saline controls in 
analgesia elicited by 4 min of continuous 2.5 mA 
footshock (Fig. 2A). These data demonstrate analge- 
sic cross-tolerance between morphine and the two 
naloxone-sensitive forms, but not the naloxone-in- 
sensitive form, of stress analgesia 36. They replicate 
our previous finding of morphine cross-tolerance 
with analgesia from long-duration, intermittent foot- 
shock 19 and give further evidence for the opioid na- 
ture of stress analgesia from 1 min of continuous foot- 
shock. 
Animals made tolerant to morphine also man- 
ifested cross-tolerance to analgesia from 3 min of 
continuous footshock at 2.0 mA (Fig. 2B), parame- 
ters known to cause analgesia sensitive to an opiate 
antagonist 36. Cross-tolerance was not seen between 
morphine and analgesia from the more intense 3.5 
mA footshock paradigm known to elicit analgesia in- 
sensitive to an opiate antagonist 36. 
EXPERIMENT 2 
The results of experiment 1 demonstrate that 
cross-tolerance with morphine, like sensitivity to 
opiate antagonists 36, can be differentially affected by 
variations in the temporal or intensive parameters of 
footshock. Less severe (briefer or less intense) con- 
tinuous footshock, as well as long duration, intermit- 
tent footshock, were seen to evoke opioid-mediated 
stress analgesia, whereas more severe (longer or 
more intense) continuous footshock caused non- 
opioid stress analgesia. The question remained 
whether the two different paradigms of opioid stress 
analgesia share a common opioid substrate. Experi- 
ment 2 addressed this question by investigating 
whether the two opioid forms of analgesia, and only 
these forms, manifest tolerance with repetition and 
cross-tolerance with each other. 
Methods 
Thirty rats were randomly assigned to 3 equal 
groups. On day 1, groups were stressed using 1 min of 
continuous, 4 min of continuous or 20 min of inter- 
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mittent 2.5 mA footshock and assessed for analgesia 
as described in experiment 1. All animals were then 
stressed daily for 14 more days, using the same foot- 
shock parameters to which they had been exposed on 
day 1. On day 15, analgesia was measured again to 
assess tolerance. On the next two days, all rats were 
exposed in counterbalanced order to the two shock 
paradigms they had not yet experienced and tested 
for analgesia once again to assess cross-tolerance. 
Results were analyzed using two separate analyses 
of variance for each shock paradigm. The cross-toler- 
ance data were analyzed using a 2-way analysis of 
variance (group x trials) with one repeated measure, 
as before. The tolerance data were analyzed using a 
2-way analysis of variance (session x trials) with two 
repeated measures. Tukey's tests were used for ap- 
propriate posthoc comparisons 11. Analgesia scores 
were again calculated for each animal. 
Twenty additional rats were divided into two equal 
groups. One group was administered i min of contin- 
uous 2.5 mA footshock daily for 14 days, whereas the 
other group served as non-shocked controls. On day 
15 and 16, all animals were exposed to 3 min of con- 
tinuous footshock at 2.0 mA and 3.5 mA in counter- 
balanced order and tested for analgesia as before. 
Data were analyzed using a 2-way analysis of vari- 
ance with one repeated measure. 
Results 
Animals given 14 daily sessions of 1 min, 2.5 mA 
continuous footshock manifested tolerance to that 
form of stress analgesia, demonstrating significantly 
less analgesia on day 15 than on day 1 (P < 0.05) 
(Fig. 3A). In accordance with our earlier report 19, 
rats shocked repeatedly with 20 min of intermittent 
footshock also manifested significant tolerance (P < 
0.05) (Fig. 3A). In contrast, animals exposed to 4 
min of continuous 2.5 mA footshock did not show sig- 
nificant tolerance (Fig. 3A). This non-opioid form of 
stress analgesia also failed to show cross-tolerance to 
either of the other two stress paradigms (Fig. 3A). 
That is, animals given 15 days of the 4 min footshock 
did not differ from naive animals in analgesia elicited 
by the 1 or 20 min paradigms (Fig. 3A), and animals 
receiving 15 sessions of either of these latter two par- 
adigms did not differ from naive animals in stress 
analgesia elicited by the 4 min footshock. 
Of particular interest, the 1 and 20 min opioid par- 
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Fig. 3. Stress analgesia elicited by several paradigms of foot- 
shock in naive control rats and rats previously shocked repeat- 
edly with either 1 min of continuous. 4 min of continuous or 20 
rain of intermittent footshock (2.5 mA). A: animals previously 
shocked repeatedly with either the 1 or 20 min paradigm 
showed significantly less analgesia than controls when shocked 
on the test day with the 1 or 20 min but not the 4 min paradigm. 
Animals previously shocked repeatedly with the 4 min para- 
digm showed analgesia not different from controls when 
shocked on the test day with any of these paradigms. B: animals 
previously shocked repeatedly using the 1 min paradigm 
showed significantly less analgesia than controls when shocked 
with the 2.0 mA, but not the 3.5 mA, 3 min continuous foot- 
shock. 
adigms, which produce analgesia showing both nap 
oxone-sensitivity 36 and cross-tolerance with mor- 
phine (experiment 1), also manifest cross-tolerance 
with each other. That is, animals given repeated ex- 
posure to either 1 min continuous or 20 min intermit- 
tent footshock showed significantly less analgesia 
than naive controls when exposed to the other one (P 
< 0.05) (Fig. 3A). This cross-tolerance between 
opioid forms of  stress analgesia suggests that they not 
only share a common neurochemical basis, as sug- 
gested by experiment 1, but that they also share a 
common site of action for this neurochemistry. 
Similarly, cross-tolerance developed between the 
opioid forms of stress analgesia elicited by 1 min of 
2.5 mA continuous footshock and 3 min of 2.0 mA 
continuous footshock. Thus, animals repeatedly 
shocked with the former stress paradigm showed sig- 
nificantly less analgesia when shocked with the latter 
than did naive controls (P  < 0.05) (Fig. 3B). Such 
cross-tolerance was not apparent with the 3 min, 3.5 
mA non-opioid stress analgesia paradigm (Fig. 3B). 
DISCUSSION 
In experiment 1, analgesia from the less severe 
(lower intensity or briefer duration), but not the 
more severe, continuous footshock paradigms was 
reduced in morphine-tolerant rats. This demonstra- 
tion of differential cross-tolerance with morphine ex- 
tends our previous findings using opiate antagonist 
drugs 33,36 suggesting that opioid and non-opioid 
forms of stress analgesia can be reliably produced by 
varying the severity of continuous footshock. We 
previously found, and confirm here, that oploid and 
non-opioid forms of stress analgesia also derive from 
varying the temporal pattern of footshock (long-du- 
ration intermittent vs brief continuous) ~, :~". Thus, in 
experiment 1, analgesia from 20 min of intermittent 
(1 s on every 5 s) footshock manifested cross-toler- 
ance with morphine, whereas that from the same in- 
tensity and total duration of continuous footshock {4 
min) did not. 
The results of experiment 2 provide additional evi- 
dence for the opioid and non-opioid bases of the anal- 
gesia caused by footshocks that differ in their severity 
or temporal pattern. Analgesia from less severe con- 
tinuous footshock and from prolonged intermittenl 
footshock manifested tolerance with repetition and 
cross-tolerance with each other, Our recent finding 
that these paradigms of stress analgesia show cross- 
tolerance with naloxone-sensitive analgesia pro- 
duced by stimulation of the rat periaqueductat gray 
mat teP 5, also is consistent with the view that these 
forms of stress analgesia are opioid mediated. By 
contrast, analgesia from the more severe continuous 
footshock paradigms tested in experiment 2 mani- 
fests neither tolerance nor cross-tolerance with any 
other paradigm of stress analgesia nor with stimula- 
t ion-produced analgesia 3s. These findings, as well as 
those of experiment 1 demonstrating no cross-toler- 
ance between morphine and such non-opioid stress 
analgesia emphasize the possible clinical implications 
of understanding the mechanisms underlying this 
analgesia. Unfortunately, such investigations have 
not yet yielded definitive answers about the neuro- 
chemical mediation of non-opioid forms of stress 
analgesia, although histamine zL~',-~l, acetylcholine -~, 
dopamine ~0 and serotonin ~0 have all been implicated. 
The fact that cross-tolerance develops between 
opioid forms of stress analgesia from continuous and 
intermittent footshock (experiment 2) points to a 
common neural substrate involved in their media- 
tion. The locus of this substrate has yet to be deter- 
mined: both brain and spinal cord seem to be impor- 
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tant since analgesia from all stress parad igms exam- 
ined thus far are reduced by thoracic  spinal le- 
sions 13.21,36. Despi te  their  similarit ies,  the two para-  
digms of opioid  stress analgesia also differ from one 
another  in several  respects.  Whereas  opioid  analge- 
sia from pro longed  in termit tent  footshock appears  to 
rely on adrenal  medul lary  enkephal ins  22, central  cho- 
linergic mechanisms iv, and the integri ty of the fore- 
brain 13,36, opioid analgesia from cont inuous foot- 
shock relies solely on opioids of central  origin (inde- 
penden t  of pi tui tary and adrenal  glands) 36 and is un- 
affected by cholinergic recep tor  b lockade  34, decere-  
brat ion 13.36 and deep  pen tobarb i ta l  anesthesia  36. The 
stimuli activating these neural ly,  hormonal ly  and 
neurochemical ly  discrete opioid  systems appear  to 
differ. Whereas  opioid stress analgesia  from pro-  
longed in termit tent  footshock seems to depend  on 
the animal 's  learning that  the stressor is inescapa- 
ble 23,24,36, opioid stress analgesia  from continuous 
footshock seems to depend  pr imari ly  on the physical 
proper t ies  of the stressor (i.e. dura t ion or  intensity) 
rather  than higher brain processingt3, 36 or even per-  
ception of the stressor as 'stressful '36. 
Recalling that analgesia from 4 rain of footshock 
shows no tolerance with repet i t ion whereas  that  from 
1 min of footshock does,  it is intriguing to note that  
rats repea ted ly  given the 4-rain shock show no cross- 
tolerance to the 1 min shock despi te  the fact that  they 
obviously receive the 1 min shock daily within the 
4-min paradigm.  This lack of cross- tolerance be- 
tween opioid (1 min) and non-opioid  (4 min) forms of 
stress analgesia gives fur ther  evidence that their  sub- 
strates are act ivated independently32, 36. This finding 
also suggests, however ,  that  an interact ion occurs be- 
tween these substrates.  It has been proposed  that  col- 
lateral inhibit ion occurs be tween opioid and non- 
opioid pain- inhibi tory systems 12. Al though  in our 
studies nei ther  opia te  antagonists  nor to lerance to 
opioids (e.g. morphine  or opioid stress analgesia)  
have the potent ia t ing effect on non-opio id  stress 
analgesia predic ted  by this model ,  nonetheless ,  dur- 
ing the last 3 rain of the 4-min footshock paradigm 
something happens  to prevent  the to lerance that 
would occur if the animal had received only the first 
rain of footshock.  
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